Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance

A Deadly Infodemic: Social Media and the Power of COVID-19 Misinformation

(2022) Michael A Gisondi et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials

(2022) Julia W. Haas et al.   JAMA Network Open

Lost in Translation: A Multilingual Survey of Interlinguistic Variations in Terms Used in Pharmacovigilance

(2022) Jeffrey K. Aronson   DRUG SAFETY

Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse

(2021) Priya Bahri et al.   DRUG SAFETY

The COVID‐19 pandemic: agile versus blundering communication during a worldwide crisis

(2021) Gaby‐Fleur Böl   EMBO REPORTS

The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards

(2021) Meredith Y Smith et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Erice Call for Change: Utilising Patient Experiences to Enhance the Quality and Safety of Healthcare

(2020) Elena Rocca et al.   DRUG SAFETY

Post‐market safety communication for protection of public health: a comparison of regulatory policy in Australia, Canada, the European Union, and the United States

(2020) Alice L. Bhasale et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance

(2020) Marco Tuccori et al.   DRUG SAFETY

The COVID-19 social media infodemic

(2020) Matteo Cinelli et al.   Scientific Reports

The utility of real‐world evidence for benefit‐risk assessment, communication, and evaluation of pharmaceuticals: Case studies

(2020) Christine A. Radawski et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem

(2019) Aaron S. Kesselheim et al.   DRUG SAFETY

‘Engagement’ of patients and healthcare professionals in regulatory pharmacovigilance: establishing a conceptual and methodological framework

(2019) Patrick Brown et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy

(2019) Janet Sultana et al.   DRUG SAFETY

The Pharmaceuticals and Medical Devices Agency's Approach to Facilitate Risk Communication and Its Challenges

(2018) Emiko Kondo et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action

(2018) Anna Radecka et al.   DRUG SAFETY

Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis

(2018) Irma Convertino et al.   DRUG SAFETY

CIOMS Guide To Vaccine Safety Communication – Executive summary

(2018) Priya Bahri et al.   VACCINE

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

(2017) Emilie Karafillakis et al.   VACCINE

Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature

(2016) Dominic Way et al.   DRUG SAFETY

Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs

(2016) Rebecca Dickinson et al.   BMJ Open

“Collaborative care” is preferable to “patient centred care”

(2016) JK Aronson et al.   BMJ-British Medical Journal

Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital

(2016) M.I. Geer et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

“Collaborative care” is preferable to “patient centred care”

(2016) JK Aronson et al.   BMJ-British Medical Journal

Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications

(2015) Aaron S. Kesselheim et al.   DRUG SAFETY

The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance

(2015) Priya Bahri et al.   DRUG SAFETY

Nudge Versus Boost: How Coherent are Policy and Theory?

(2015) Till Grüne-Yanoff et al.   MINDS AND MACHINES

Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist

(2015) Christine Radawski et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Present State and Future Tasks of “Drug Guide for Patients”

(2015) Makiko Isozaki   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

A cross-sectional pilot study assessing needs and attitudes to implementation of Information and Communication Technology for rational use of medicines among healthcare staff in rural Tanzania

(2014) Jessica Nilseng et al.   BMC Medical Informatics and Decision Making

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012

(2014) Heidi J. Larson et al.   VACCINE

Using a Drug Facts Box to Communicate Drug Benefits and Harms

(2013) Lisa M. Schwartz   ANNALS OF INTERNAL MEDICINE

Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers

(2013) Lyndal J Trevena et al.   BMC Medical Informatics and Decision Making

When Direct Health-Care Professional Communications Have an Impact on Inappropriate and Unsafe Use of Medicines

(2013) K C Reber et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Globalization of Risk and Risk Perception

(2013) Heidi Larson et al.   DRUG SAFETY

Healthcare Professionals’ Self-Reported Experiences and Preferences Related to Direct Healthcare Professional Communications

(2013) Sigrid Piening et al.   DRUG SAFETY

Challenges of Drug Risk Communications in the Philippines

(2013) Kenneth Hartigan-Go   DRUG SAFETY

Good Decision Making Requires Good Communication

(2013) Baruch Fischhoff   DRUG SAFETY

Adverse Drug Reactions

(2013) Anthony R. Cox et al.   DRUG SAFETY

Risk Perception and Communication in Sub-Saharan Africa

(2013) Alexander Dodoo et al.   DRUG SAFETY

Risk Communication and the Pharmaceutical Industry

(2013) Brian Edwards et al.   DRUG SAFETY

Protecting the People?

(2013) Bruce Hugman   DRUG SAFETY

How to Improve Communication for the Safe Use of Medicines?

(2013) Priya Bahri et al.   DRUG SAFETY

Focusing on Risk Communication About Medicines

(2013) Priya Bahri et al.   DRUG SAFETY

The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands

(2013) Sigrid Piening et al.   DRUG SAFETY

Risk Communication with Patients

(2012) Makoto Hirose   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance

(2011) Ahmed A Adedeji et al.   MALARIA JOURNAL

Public Pharmacovigilance Communication

(2010) Priya Bahri   DRUG SAFETY

Using icon arrays to communicate medical risks: Overcoming low numeracy.

(2009) Mirta Galesic et al.   HEALTH PSYCHOLOGY